Healthcare · Active clinical trials
Brazil is firmly among the world's centers for clinical research: in 2026, 110 units active trials were registered here. This is the 28th result among 197 countries. A developed healthcare system, major pharmaceutical companies in São Paulo and Rio de Janeiro, and a high population density make the country attractive for international pharma companies. Oncology and cardiology drugs are particularly actively studied — Brazil has become a gateway for trials in Latin America.
Data for 2026 · unit: units
Position
#28 / 197
Brazil world ranking
Country position on the scale from last to first place for this indicator.
BR
#28
#197#1
Trend
Change over time
Change in indicator over the available period.
5
1990
20
2000
60
2010
95
2020
200
2025
110
2026
Values — units
Comparison
Top countries by Active clinical trials
Where Brazil stands in the world ranking.
1
USUSA
12 K
1
CNChina
12 K
3
GBUnited Kingdom
3.5 K
3
JPJapan
3.5 K
5
INIndia
2.5 K
6
FRFrance
1.5 K
6
CACanada
1.5 K
8
DEGermany
1.2 K
Full world rankingarrow_forward
People also search for
Other pages of the reference by this indicator.
Frequently asked questions
Active clinical trials in Brazil — how much?
Based on 2026 data — 110 units. This is rank #28 out of 197 countries.
What is Brazil's rank by Active clinical trials?
Brazil ranks #28 out of 197 countries in the world ranking by «Active clinical trials».
How has Active clinical trials changed in Brazil?
Over the available period the indicator changed from 5 to 110 units.